Claim OwnershipSurgOnc Today®
Subscribed: 47Played: 1,966
Subscribe
© Society of Surgical Oncology
Description
SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their respective fields and are members of SSO.
231 Episodes
Reverse
In this new episode of Speaking of SurgOnc, Dr. Rick Greene & Dr. Jamie Rand discuss the article: Omission of Axillary Lymph Node Dissection in Patients with pT0-2 ER+/HER2− Breast Cancer with 3–5 Positive Lymph Nodes Undergoing Adjuvant Systemic Therapy and Radiation Does Not Impact Overall Survival: A Cancer Database Analysis, from the February 2026 issue of the Annals of Surgical Oncology.
In this episode of SurgOnc Today, join Dr. Ana Refinetti and Dr. Shruti Zaveri as they interview Dr. Iryna Jacinto, a recent SSO ICDE participant who is spearheading breast cancer care programming in Angola.
In this episode of SurgOnc Today, members of the Constitution and Bylaws Committee with their integral connection to the Society's governance structure, interview the new CEO, Ms. Patti Stella.
"Mentorship Basics" is a podcast series by the Women in Cancer Surgery (WICS) Committee exploring mentorship in surgical oncology. In this episode, experienced mentor Chantal Reyna, MD, MHA, FACS, FSSO, is interviewed by WICS members Christin Collins, DO, and Deba Sarma, MD, offering insights into mentorship from the mentor's perspective. This conversation provides practical guidance and reflection that will be valuable both for individuals seeking mentors and for those interested in becoming effective mentors themselves.
Leaders in PSM and co-creators of the Yale consensus guidelines meet to discuss key aspects of the recently updated consortium recommendations.
In this new episode of Speaking of Surgonc, Dr. Rick Greene & Dr. Elena Panettieri discuss the article: Short- and Long-Term Outcomes After Hepatectomy in Patients Receiving Triplet Versus Doublet Preoperative Chemotherapy for Colorectal Liver Metastases, from the January 2026 issue of the Annals of Surgical Oncology.
In this episode of SurgOnc Today® Dr. Eyal Mor is joined by Dr. Myles Smith, Dr. Cornelius Thiels, Dr. Anai Kothari, and Dr. Heather Lyu to discuss Innovation in Surgical Oncology: Harnessing AI and AR in the Operating Room. Together, they explore how emerging technologies are transforming surgical planning, intraoperative navigation, and education — and how innovation can be integrated into everyday cancer care.
In this episode of Outside the OR, Steven C. Katz, MD, FACS shares his journey at the intersection of surgical oncology and industry. From clinical insight to drug development, Dr. Katz discusses how surgeons can play a pivotal role in advancing innovation, translating research into therapeutics, and collaborating with industry partners to bring new treatments to patients. Tune in for an engaging conversation about leadership, entrepreneurship, and how surgical oncologists can help shape the future of drug discovery.
In this episode of SurgOncToday, Everett Warren, MD, MAT, is joined by Maggie DiNome, MD, FACS, and Micaela Weaver, DO, FSSO, FACS, to discuss lessons learned in setting up a clinical practice that is both busy and diverse yet tailored to their individual interests.
In this episode of SurgOnc Today, Drs. Shelley Hwang and Mediget Teshome are joined by international leaders Drs. Wonshik Han and Jeong Eon Lee to reflect on key insights from the 2025 Global Breast Cancer Conference and look ahead to future directions. The conversation highlights evolving trends in breast cancer care, including surgical de-escalation, care of younger and premenopausal patients, emerging technologies, and opportunities for continued global collaboration between the SSO and partners across Asia.
On this episode of SurgOnc Today, Dr. Zhi Ven Fong discusses with Dr. Christopher Childers, Dr. Erin Strong, Dr. Udai Sibia, & Dr. David Litvak, what surgical oncologists should know about value-based care and how it impacts their practices. The speakers also touch on real-world examples and detail how surgical oncologists can take an active role in optimizing value-based care within their hospital and health systems.
In this series "evidence today and tomorrow", the HPB disease site working group of the SSO explores current gaps in HPB surgical oncology, highlighting existing evidence and ongoing work aimed at filling those gaps. In this episode, Drs. Julie Hallet and Patricio Polanco, chair and vice-chair of the HPB disease site working group are joined by Drs. Ajay Maker, Rebecca Snyder, and Giovanni Marchegiani to review evidence in the management of pancreatic cystic neoplasms.
In this episode of SurgOnc Today, Dr. Zhi Ven Fong, of the HPB Disease Site Work Group interviews Dr. Yorick L. van de Pavert about the ENDURO Trial's (surgical vs endoscopic gastrojejunostomy bypass) design, implementation, and primary and secondary endpoints. If you did not check out part 1, please be sure to visit SurgOnc Academy for the full series: https://learn.surgonc.org/courses/112569
In this episode of SurgOnc Today, we discuss the recently updated ASCO guidelines for axillary staging with sentinel lymph node biopsy in breast cancer, as well as considerations for their application in a multidisciplinary setting. This episode is moderated by Dr. Ashley Woodfin from the University of Wisconsin, who is joined by Dr. Clara Park from Brigham and Women's Hospital and Dr. Andrea Abbott from Medical University of South Carolina for a in-depth discussion regarding the guidelines implementation and important considerations.
In this episode of Outside the OR, we explore how collaboration between the Society of Surgical Oncology (SSO) and the American College of Surgeons Cancer Surgery Standards Program (ACS CSSP) is helping raise the bar for cancer care nationwide. Joined by Dr. Matthew H.G. Katz and Dr. Tina J. Hieken, we discuss how shared standards, multidisciplinary alignment, and surgeon leadership translate into better support for surgeons, and better outcomes for patients. Tune in for a thoughtful conversation on why collaboration matters and how collective efforts are shaping the future of cancer surgery.
In this new episode of Speaking of SurgOnc, Dr. Rick Greene and Dr. Shayna Showalter discuss recently updated considerations by the SSO Breast Task Force regarding bilateral and contralateral risk-reducing mastectomy, highlighting important considerations for clinical practice, as reported in the editorial, "Highlights and Perspectives from The Society of Surgical Oncology's Statements on Bilateral and Contralateral Risk-Reducing Mastectomy."
In this episode of SurgOnc Today's Surgical Oncology Insight series, Dr. Monisha Sudarshan, Section Editor of the Thoracic Editorial Board section, discusses with Dr. Erin A. Gillaspie her paper "Immunotherapy in gastroesophageal adenocarcinoma: What is the state of management?".
In this episode of SurgOnc Today, Casey Allen leads a discussion with Oluwadamilola Fayanju, Laura Dominici, Michael Egger, Cristina O'Donoghue, and Winta Mehtsun, exploring how value-based care principles intersect with access, equity, and health policy in surgical oncology. The conversation highlights social determinants of health, rural outreach, and global initiatives advancing high-quality, value-based cancer surgery.
In this episode, join the SSO HPB disease site working group as they count down the final five studies in the 2025 HPB wrapped. This episode dives into some of the year's most practice-changing publications in HPB surgical oncology: the ROC'N'ROLL Trial, best practices neoadjuvant therapy for pancreas cancer, the PANDRA-II Trial, the use of SBRT for resectable pancreas cancer, and the PREHEP Trial. Hear our guests Dr. Colin Court and Dr. Winnie Lo as they review the studies and unpack what these findings mean for clinical practice.
In this episode, join the SSO HPB disease site working group as they count down the first five studies in the 2025 HPB wrapped. This episode dives into some of the year's most practice-changing publications in HPB surgical oncology: the Preopanc-2 Trial, the Collision Trial, the Tesla trial, the use of Kras in ablation for Colorectal Liver Metastases, and the ENDURO Trial. Hear our guests Dr. Sandra DiBrito and Dr. Neha Lad as they review the studies and unpack what these findings mean for clinical practice.
Comments
Download from Google Play
Download from App Store
United States